CAF metabolism in high grade serous ovarian cancer

Prof Sara Zanivan

Starting Salary from £31,604 to £41,929 (Depending on experience) plus relocation allowance and sponsorship and fees for a Skilled Workers Visa where applicable.

Initial 3-year fixed term contract.


A postdoctoral position is available in the Tumour Microenvironment & Proteomics group headed by Professor Sara Zanivan. The group is a vibrant team, which aims to understand how cancer-associated fibroblasts (CAFs) influence breast and ovarian cancer development and metastatic spread. We are currently looking for a highly skilled and motivated postdoc to join our multidisciplinary team to study CAF metabolism in high grade serous ovarian cancer (

This post will study how CAF metabolism influences the formation of a tumour microenvironment permissive for ovarian cancer growth and development. To achieve that, we will use heterotypic cell cultures, state-of-the-art metabolomics and proteomics technologies, and genetically modified in vivo models.

Applicants must have a PhD in a relevant field, be ambitious and driven by scientific curiosity. Previous experience with regard to cell metabolism is highly recommended, and experience or interest in CAFs, in vivo cancer models and omics data analysis would be an advantage.

To find out more about this unique opportunity to establish advanced skills and expertise in this exciting field please contact: Professor Sara Zanivan

The Cancer Research UK Beatson Institute is committed to increase the number of female scientists at this level and encourages female applicants to apply. We have recently introduced a highly attractive maternity policy which provides 12-18 months support and funding for postdocs wishing to take time off to spend with their children.

The closing date for applications is the 10 October 2021



Research Mahnoor 290x200

Read more about the Research Groups working at the Beatson Institute.



Seminars 2021

Find out more about our seminars including our Distinguished Seminar Programme.